Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech

Summary by The Manila Times
Stunning Brain-Cancer Data Are Putting NeOnc’s Nose-to-Brain Delivery Platform, and Its Broader Potential, Front and Center DENVER, Aug. 13, 2026 (GLOBE NEWSWIRE)

1 Articles

The Manila TimesThe Manila Times
Lean Right

The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech

Stunning Brain-Cancer Data Are Putting NeOnc’s Nose-to-Brain Delivery Platform, and Its Broader Potential, Front and Center DENVER, Aug. 13, 2026 (GLOBE NEWSWIRE)

·Manila, Philippines (the)
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Manila Times broke the news in Manila, Philippines (the) on Thursday, August 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Biotech icon

Biotech

Denver, Colorado icon

Denver, Colorado

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal